[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Stakeholder](https://github.com/mm80843/T3.5/tree/pages/docs/Stakeholder/index.md) >> Individual ID:PBN__Stakeholder_698 

# __Laboratory technicians__

## Category to which it belongs

* [Variety of personnel involved in different roles, such as contractors, staff, administrators, technicians, and professionals in specific fields.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_260.md)

## Closest similar item

* [Clinical laboratory](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_688.md)
* [Laboratories](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1051.md)
* [Laboratory and research](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_167.md)
* [Laboratory management](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_700.md)
* [Laboratory personnel](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1557.md)
* [Laboratory researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_5.md)
* [Laboratory supervisors](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1825.md)
* [Medical laboratories](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1575.md)
* [Technicians](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1824.md)
* [Testing laboratories](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1155.md)

## Risk affecting this stakeholder

* [Accumulation of extraneous nucleic acids during the concentration process of wastewater samples.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1161.md)
* [Contamination of glass coverslips](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3655.md)
* [Desire to keep required sample sizes low for economic shipping.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3656.md)
* [Detection of sars-cov-2 signal in peg-precipitated filtrate fraction](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3657.md)
* [Development of lab-in-a-tube, lab-in-a-box, and lab on-a-drone systems for disease diagnosis](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3659.md)
* [Discrepancies between laboratories due to factors such as qpcr platforms, pcr inhibitors, nucleic acid extraction efficiency, and low levels of targets](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3673.md)
* [Discrepancies in rt-qpcr n1, n2, and n3 assays for water samples](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3676.md)
* [Emerging technology built by the transition of functions from biological systems](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3686.md)
* [Enumeration of hcov 229e viral stocks using tcid50 technique](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5207.md)
* [Enveloped viruses like mhv coronavirus are susceptible to inactivation by mechanical stress.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5222.md)
* [Exposure to aerosolized virus particles during the experimental protocol](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5224.md)
* [Failure to detect sars-cov-2 rna on control sampler](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5229.md)
* [Failure to properly disinfect the work area](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5500.md)
* [Fecal becoming an alternative route for clinical diagnostic testing for covid-19.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6048.md)
* [Handling sars-cov-2 in wastewater samples increases the risk of exposure to the virus.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6049.md)
* [Handling virus infectivity assays without proper safety protocols](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7375.md)
* [Improper disposal of contaminated materials after the rt-pcr assay.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7379.md)
* [Improper handling of sewage samples](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7390.md)
* [Inaccurate identification of specific diseases due to biomarkers not being specific to a given disease, leading to misdiagnosis and ineffective containment measures.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7720.md)
* [Inaccurate temperature control during pcr process leading to compromised amplification](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_9427.md)
* [Inadequate cleaning of pcr equipment leading to contamination of samples](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10295.md)
* [Inadequate handling of amplified products leading to cross-contamination](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10296.md)
* [Inadequate handling of high-throughput sequencing equipment and reagents can pose a risk of contamination and spread of contagious diseases.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10298.md)
* [Inconsistent quantification of sars-cov-2 in sewage samples](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10737.md)
* [Inconsistent results between different assays when concentrations are low](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10738.md)
* [Lack of standardization in laboratory protocols for detecting sars-cov-2 and determining viral content](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10739.md)
* [Manual extraction of dust from filters](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10741.md)
* [Optimization of pcr conditions may result in false-positive results.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10742.md)
* [Pathogen detection and analysis](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10755.md)
* [Potential artefactual reduction in the viability of sampled virus by air sampling devices](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10759.md)
* [Potential contamination during rna extraction process](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10761.md)
* [Potential contamination of reaction mix due to incorrect handling or storage of reagents.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11787.md)
* [Potential contamination of reagents and probes](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11788.md)
* [Potential cross-contamination during testing](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11789.md)
* [Potential rt-qpcr contamination during rna extraction and setup](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11982.md)
* [Presence of rt-qpcr inhibition in wastewater samples](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_12058.md)
* [Presence of viral signal in solid materials on the filter](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_12206.md)
* [Prolonged lysis phase during rna extraction](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_14266.md)
* [Reliance on protocol without validation using expensive commercial kits](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_14267.md)
* [Sequencing and bioinformatics processes for taqman rt-qpcr products](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_16037.md)
* [Sequencing bacterial communities](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_16041.md)
* [Sodium hypochlorite disinfectant has strong corrosiveness](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_16047.md)
* [Storage of hcov 229e stocks at -80Â°c](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_16048.md)
* [Testing method limitations for viral concentration from water samples](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_16049.md)
* [Transportation of biological samples by drones](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17087.md)
* [Unamplified synthetic dna used to set up pcr conditions may introduce contamination during subsequent experiments.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17863.md)
* [Uncertainty in the suitability of dpcr for certain sample types](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18335.md)
* [Untested retention of wastewater samples before the sars-cov-2 pandemic as control.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18336.md)
* [Use of nested pcr with multiple cycles can increase the risk of contamination and false positives.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18616.md)
* [Use of outdated or expired reagents in the reaction mix.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_19014.md)
* [Use of rt-qpcr assays for wastewater monitoring](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_19624.md)
* [Variability in efficiency of dna/rna extraction from pcr inhibitor rich samples](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_19625.md)
* [Variability in sensitivity of primer/probe sets for sars-cov-2 rna detection](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_19628.md)
* [Variation in pmmov levels across samples with a standard deviation of 1.34 c t units](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_20257.md)
* [Variation in viral signal degradation during storage at 4 u00b0c](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_20258.md)
* [Variations in sample preparation and testing leading to differences in the effectiveness of the coating.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_20259.md)
* [Viral rna presence in air samples](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_20260.md)
* [Virus isolation and culture in biosafety level 3 bsl-3 laboratory](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_20262.md)

## Risks that can be mitigated by this stakeholder

* [Degradation of viral signal in storage](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2343.md)
* [Potential rt-qpcr contamination during rna extraction and setup](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3655.md)
* [Presence of rt-qpcr inhibition in wastewater samples](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3656.md)
* [Sequencing and bioinformatics processes for taqman rt-qpcr products](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3657.md)

## This Stakeholder belongs to this Stakeholder Group

* [Health organisations](https://github.com/mm80843/T3.5/blob/pages/StakeholderGroup/PBN__StakeholderGroup_7.md)
* [Research organisations](https://github.com/mm80843/T3.5/blob/pages/StakeholderGroup/PBN__StakeholderGroup_0.md)
* [Workers](https://github.com/mm80843/T3.5/blob/pages/StakeholderGroup/PBN__StakeholderGroup_8.md)

## This Stakeholder belongs to this Stakeholder Subgroup

* [Medical and healthcare personnel](https://github.com/mm80843/T3.5/blob/pages/StakeholderSubgroup/PBN__StakeholderSubgroup_15.md)

## Type of the stakeholder

* [At risk](https://github.com/mm80843/T3.5/blob/pages/Stakeholder_Type/PBN__Stakeholder_Type_2.md)
* [Risk owner](https://github.com/mm80843/T3.5/blob/pages/Stakeholder_Type/PBN__Stakeholder_Type_1.md)

